We are live on ! Find out more
OI

Oakbrook Investments Portfolio holdings

AUM $39.2M
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+1.07%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.08%
5 Year Est. Return
+53.42%
10 Year Est. Return
AUM
$1.55B
AUM Growth
-$13.1M
Cap. Flow
-$20.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
21.91%
Holding
600
New
57
Increased
128
Reduced
312
Closed
80

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$15.8M
2
GE icon
GE Aerospace
GE
+$13.3M
3
WMT icon
Walmart Inc
WMT
+$7.69M
4
INTC icon
Intel
INTC
+$4.72M
5
MMM icon
3M
MMM
+$4.24M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12M
2
PFE icon
Pfizer
PFE
+$11.2M
3
RTX icon
RTX Corp
RTX
+$7.61M
4
UNH icon
UnitedHealth
UNH
+$7.08M
5
VZ icon
Verizon
VZ
+$6.27M

Sector Composition

Rank Sector Weight
1 Healthcare 16.28%
2 Industrials 15.39%
3 Financials 14.31%
4 Technology 14.24%
5 Consumer Staples 11.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
51
Eli Lilly
LLY
$1.04T
$7.09M 0.46%
98,530
+2,950
+3% +$223K
WBA
52
DELISTED
Walgreens Boots Alliance
WBA
$7.03M 0.45%
83,495
+32,350
+63% +$2.58M
USB icon
53
US Bancorp
USB
$100B
$6.85M 0.44%
168,727
-25,750
-13% -$1.03M
ABT icon
54
Abbott
ABT
$183B
$6.81M 0.44%
162,697
+3,750
+2% +$149K
UNP icon
55
Union Pacific
UNP
$176B
$6.69M 0.43%
84,085
-14,250
-14% -$1.1M
CVS icon
56
CVS Health
CVS
$126B
$6.59M 0.42%
63,546
+42,925
+208% +$4.17M
DHR icon
57
Danaher
DHR
$140B
$6.43M 0.41%
100,894
+47,034
+87% +$2.8M
MDLZ icon
58
Mondelez International
MDLZ
$79.9B
$6.41M 0.41%
159,880
+2,000
+1% +$81.4K
LMT icon
59
Lockheed Martin
LMT
$133B
$6.29M 0.4%
28,390
VZ icon
60
Verizon
VZ
$193B
$6.21M 0.4%
114,767
-125,400
-52% -$6.27M
BIIB icon
61
Biogen
BIIB
$30.5B
$6.08M 0.39%
23,350
+1,416
+6% +$374K
SBUX icon
62
Starbucks
SBUX
$121B
$5.97M 0.38%
100,025
-8,235
-8% -$480K
MMM icon
63
3M
MMM
$93.9B
$5.84M 0.38%
41,951
+33,010
+369% +$4.24M
AXP icon
64
American Express
AXP
$236B
$5.63M 0.36%
91,650
-9,950
-10% -$579K
CB icon
65
Chubb
CB
$136B
$5.63M 0.36%
47,217
+28,192
+148% +$3.24M
ABBV icon
66
AbbVie
ABBV
$435B
$5.33M 0.34%
93,217
-2,250
-2% -$125K
FDX icon
67
FedEx
FDX
$73.5B
$5.05M 0.33%
31,031
-944
-3% -$131K
AIG icon
68
American International
AIG
$42.5B
$4.84M 0.31%
89,485
-12,350
-12% -$667K
LOW icon
69
Lowe's Companies
LOW
$123B
$4.79M 0.31%
63,216
-7,600
-11% -$536K
GD icon
70
General Dynamics
GD
$104B
$4.61M 0.3%
35,100
-1,075
-3% -$142K
ADBE icon
71
Adobe
ADBE
$103B
$4.58M 0.29%
48,770
+20,400
+72% +$1.77M
COF icon
72
Capital One
COF
$136B
$4.51M 0.29%
65,120
-1,850
-3% -$122K
PFE icon
73
Pfizer
PFE
$147B
$4.49M 0.29%
159,758
-392,446
-71% -$11.2M
RTN
74
DELISTED
Raytheon Company
RTN
$4.47M 0.29%
36,425
-850
-2% -$105K
V icon
75
Visa
V
$688B
$4.44M 0.29%
58,058
+14,950
+35% +$1.09M

Similar funds

Oakbrook Investments's Q1 2016 Portfolio in Review

As of Q1 2016, Oakbrook Investments held 600 positions worth $1.55B, down 0.84% from $1.57B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Oakbrook Investments's Q1 2016 filing shows 57 new, 128 increased, 312 reduced and 80 closed positions. Its largest new stake was Charles Schwab: 132,250 shares worth $3.71M. The largest sale was Alphabet (Google) Class A, an estimated $12M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Oakbrook Investments's largest Q1 2016 buy was Charles Schwab: 132,250 shares worth $3.71M.
  • Oakbrook Investments added most to Gilead Sciences in Q1 2016, an estimated $15.8M increase.
  • Oakbrook Investments's biggest Q1 2016 reduction was Alphabet (Google) Class A, cutting an estimated $12M.
  • Oakbrook Investments fully exited Thermo Fisher Scientific in Q1 2016, selling an estimated $6.17M.
  • Oakbrook Investments's ten largest holdings make up 22% of its $1.55B portfolio in Q1 2016.
  • Oakbrook Investments opened 57 new positions and closed 80 in Q1 2016.
  • Oakbrook Investments's portfolio value fell 0.84% quarter-over-quarter to $1.55B.

Based on Oakbrook Investments's 13F filing for Q1 2016, filed 14 Apr 2016.